DrugPatentWatch Database Preview

Avid Radiopharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AVID RADIOPHARMS INC, and when can generic versions of AVID RADIOPHARMS INC drugs launch?

AVID RADIOPHARMS INC has one approved drug.

There are two US patents protecting AVID RADIOPHARMS INC drugs.

There are thirty-seven patent family members on AVID RADIOPHARMS INC drugs in thirty-one countries and thirteen supplementary protection certificates in thirteen countries.

Summary for Avid Radiopharms Inc

International Patents:	37
US Patents:	2
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Avid Radiopharms Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-001	Apr 6, 2012		DISCN	No	No	7,687,052		Y	Y
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-002	Apr 6, 2012		RX	Yes	Yes	8,506,929		Y	Y
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-003	Apr 6, 2012		RX	Yes	Yes	8,506,929		Y	Y
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-003	Apr 6, 2012		RX	Yes	Yes	7,687,052		Y	Y
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-001	Apr 6, 2012		DISCN	No	No	8,506,929		Y	Y
Avid Radiopharms Inc	AMYVID	florbetapir f-18	SOLUTION;INTRAVENOUS	202008-002	Apr 6, 2012		RX	Yes	Yes	7,687,052		Y	Y

Non-Orange Book US Patents for Avid Radiopharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,840,866	Styrylpyridine derivatives and their use for binding and imaging amyloid plaques

International Patents for Avid Radiopharms Inc Drugs

Country	Document Number	Estimated Expiration
Singapore	173338
South Africa	200807955
Hungary	S1300028
Spain	2378785
Cyprus	1119048
Denmark	2363392

Supplementary Protection Certificates for Avid Radiopharms Inc Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1999109/01	Switzerland		PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: SWISSMEDIC 62897 09.01.2014
1	Finland
90030-3	Sweden		PRODUCT NAME: FLORBETAPIR (18F); REG. NO/DATE: EU/1/12/805 20130114
2013 00035	Denmark
2013000051	Germany		PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: EU/1/12/805 20130114
2013016	Lithuania		PRODUCT NAME: FLORBETAPIRUM; REGISTRATION NO/DATE: EU/1/12/805 20130114

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Avid Radiopharms Inc